Use of miRNA Response Sequences to Block Off-target Replication and Increase the Safety of an Unattenuated, Glioblastoma-targeted Oncolytic HSV-Reference-Cited by-同舟云学术

Use of miRNA Response Sequences to Block Off-target Replication and Increase the Safety of an Unattenuated, Glioblastoma-targeted Oncolytic HSV

Published:2015-01 Issue:1 Volume:23 Page:99-107
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Mazzacurati Lucia,Marzulli Marco,Reinhart Bonnie,Miyagawa Yoshitaka,Uchida Hiroaki,Goins William F,Li Aofei,Kaur Balveen,Caligiuri Michael,Cripe Timothy,Chiocca Nino,Amankulor Nduka,Cohen Justus B,Glorioso Joseph C,Grandi Paola

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference44 articles.

1. Oncolytic viral therapy of malignant glioma;Parker;Neurotherapeutics,2009

2. Design and application of oncolytic HSV vectors for glioblastoma therapy;Grandi;Expert Rev Neurother,2009

3. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial;Markert;Gene Ther,2000

4. Oncolytic virus therapy using genetically engineered herpes simplex viruses;Todo;Front Biosci,2008

5. Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus;Uchida;Mol Ther,2013

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses;Pharmaceutics;2024-07-25

2. Disease-modifying rdHSV-CA8* non-opioid analgesic gene therapy treats chronic osteoarthritis pain by activating Kv7 voltage-gated potassium channels;Frontiers in Molecular Neuroscience;2024-07-17

3. Integrating system biology and intratumor gene therapy by trans-complementing the appropriate co-stimulatory molecule as payload in oncolytic herpes virus;Cancer Gene Therapy;2024-06-05

4. rdHSV-CA8 non-opioid analgesic gene therapy decreases somatosensory neuronal excitability by activating Kv7 voltage-gated potassium channels;Frontiers in Molecular Neuroscience;2024-05-09

5. RNA therapies for CNS diseases;Advanced Drug Delivery Reviews;2024-05